<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Cell Infect Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Cell Infect Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Cellular and Infection Microbiology</journal-title></journal-title-group><issn pub-type="epub">2235-2988</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12098639</article-id><article-id pub-id-type="doi">10.3389/fcimb.2025.1524820</article-id><article-categories><subj-group subj-group-type="heading"><subject>Cellular and Infection Microbiology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>
<italic>In vitro</italic> impact of <italic>Streptococcus mitis</italic> on the inhibition of oral cancer cell proliferation via mitotic modulation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Inui</surname><given-names>Inori</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2882256/overview"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/></contrib><contrib contrib-type="author"><name><surname>Mochizuki</surname><given-names>Shinichi</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Hirabayashi-Nishimuta</surname><given-names>Fumika</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Yoshioka</surname><given-names>Yoshie</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Takahashi</surname><given-names>Osamu</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Sasaguri</surname><given-names>Masaaki</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Habu</surname><given-names>Manabu</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Ariyoshi</surname><given-names>Wataru</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1696385/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Yamasaki</surname><given-names>Ryota</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>*</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/807617/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Division of Infections and Molecular Biology, Department of Health Promotion, Kyushu Dental University</institution>, <addr-line>Kitakyushu, Fukuoka</addr-line>, <country>Japan</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>Division of Maxillofacial Surgery, Department of Science of Physical Functions, Kyushu Dental University</institution>, <addr-line>Kitakyushu, Fukuoka</addr-line>, <country>Japan</country>
</aff><aff id="aff3">
<sup>3</sup>
<institution>Department of Chemistry and Biochemistry, The University of Kitakyushu</institution>, <addr-line>Kitakyushu, Fukuoka</addr-line>, <country>Japan</country>
</aff><aff id="aff4">
<sup>4</sup>
<institution>Division of Oral Medicine, Department of Science of Physical Functions, Kyushu Dental University</institution>, <addr-line>Kitakyushu, Fukuoka</addr-line>, <country>Japan</country>
</aff><aff id="aff5">
<sup>5</sup>
<institution>Collaborative Research Centre for Green Materials on Environmental Technology, Kyushu Institute of Technology</institution>, <addr-line>Kitakyushu, Fukuoka</addr-line>, <country>Japan</country>
</aff><author-notes><fn fn-type="edited-by"><p>Edited by: Maurizio Sanguinetti, Catholic University of the Sacred Heart, Italy</p></fn><fn fn-type="edited-by"><p>Reviewed by: Divyashri Baraniya, Temple University, United States</p><p>Anne Lise Lund H&#x000e5;heim, University of Oslo, Norway</p></fn><corresp id="fn001">*Correspondence: Ryota Yamasaki, <email xlink:href="mailto:r18yamasaki@fa.kyu-dent.ac.jp">r18yamasaki@fa.kyu-dent.ac.jp</email>
</corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>15</volume><elocation-id>1524820</elocation-id><history><date date-type="received"><day>08</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>17</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Inui, Mochizuki, Hirabayashi-Nishimuta, Yoshioka, Takahashi, Sasaguri, Habu, Ariyoshi and Yamasaki</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Inui, Mochizuki, Hirabayashi-Nishimuta, Yoshioka, Takahashi, Sasaguri, Habu, Ariyoshi and Yamasaki</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>Recent studies have elucidated a potential correlation between oral carcinogenesis and the oral microbiome. However, few reports exist on the interaction between <italic>Streptococcus</italic> spp., the most common oral microflora bacterium, and oral cancer. In this study, we aimed to elucidate the effects of <italic>Streptococcus</italic> spp. on oral squamous cell carcinoma (OSCC) cells <italic>in vitro</italic>.</p></sec><sec><title>Methods</title><p>HSC-3 (tongue carcinoma) and Ca9-22 (gingival carcinoma) cells were used as models of OSCC cells, and their responses were examined after adding major oral <italic>Streptococcus</italic> species&#x02014;<italic>S. mitis</italic>, <italic>S. sanguinis</italic>, <italic>S. anginosus</italic>, <italic>S. salivarius</italic>, and <italic>S. mutans</italic>&#x02014;to the culture medium. Cell viability was assessed using the CCK-8 assay. Gene expression changes were analyzed using RNA sequencing and RT-qPCR followed by Gene Ontology analysis. Flow cytometry was used to observe the effects of bacteria on the cell cycle.</p></sec><sec><title>Results</title><p>Among all examined <italic>Streptococcus</italic> species, <italic>S. mitis</italic> had the strongest inhibitory effect on the growth of OSCC cells. RNA sequencing and RT-qPCR revealed an increase in the number of genes involved in mitotic nuclear division, especially <italic>DUSP1</italic>, in HSC-3 cells treated with <italic>S. mitis.</italic> Flow cytometry showed that <italic>S. mitis</italic> caused a decreased number of HSC-3 cells in the G0/G1 phase and an increased number in the G2/M phase, suggesting cell cycle arrest in the G2/M phase. Various treatments of <italic>S. mitis</italic> were used to examine the effects of intact bacteria and bacterial components on cancer cells, indicating the involvement of structural bacterial proteins.</p></sec><sec><title>Conclusions</title><p>This study, investigating the association between oral cancer cells and bacteria of the genus <italic>Streptococcus</italic>, revealed that <italic>S. mitis</italic> may play an important role in the inhibition of cancer cells.</p></sec></abstract><kwd-group><kwd>oral microbiota</kwd><kwd>
<italic>Streptococcus</italic> spp.</kwd><kwd>oral cancer</kwd><kwd>carcinoma</kwd><kwd>cell cycle</kwd><kwd>DUSP1</kwd><kwd>mitotic nuclear division</kwd><kwd><italic>Streptococcus mitis</italic></kwd></kwd-group><funding-group><award-group><funding-source id="cn001"><institution-wrap><institution>Japan Society for the Promotion of Science
</institution><institution-id institution-id-type="doi">10.13039/501100001691</institution-id></institution-wrap></funding-source><award-id award-type="contract" rid="cn001">23K17147, 23K09317, 24K12888</award-id></award-group><funding-statement>The author(s) declare that financial support was received for the research and/or publication of this article. This study was funded by JSPS KAKENHI, Grant Numbers 23K17147 and 23K09317 and partially supported by JSPS KAKENHI, Grant Number 24K12888.</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="3"/><equation-count count="0"/><ref-count count="35"/><page-count count="11"/><word-count count="4784"/></counts><custom-meta-group><custom-meta><meta-name>section-in-acceptance</meta-name><meta-value>Bacteria and Host</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><label>1</label><title>Introduction</title><p>Oral cancer encompasses a group of malignant neoplasms localized within the jaw and oral cavity. As the mucosa consists of squamous epithelium covering the entire oral cavity apart from the teeth, 90% of all oral cancer cases are classified as squamous cell carcinoma (<xref rid="B3" ref-type="bibr">Bagan et&#x000a0;al., 2010</xref>). In 2020, 377,713 cases of oral cancer and 177,757 related deaths were reported worldwide (<xref rid="B28" ref-type="bibr">Sung et&#x000a0;al., 2021</xref>). According to the Global Cancer Observatory (GCO), the incidence of oral squamous cell carcinoma (OSCC) is projected to rise by approximately 40% by 2040, with increasing mortality rates (<xref rid="B29" ref-type="bibr">Tan et&#x000a0;al., 2023</xref>). The primary treatment for oral cancer is surgical resection, but tissue loss from surgery can affect the dentition, muscles, and nerves. Since these tissues are involved in important functions, such as chewing, swallowing, and speech, the quality of life after treatment is significantly reduced in cases that require extensive resection (<xref rid="B31" ref-type="bibr">Vermaire et&#x000a0;al., 2022</xref>).</p><p>In addition to smoking, alcohol consumption, and improper oral hygiene, various systemic predisposing factors such as nutritional deficiencies, immunodeficiency, and genetic disorders are intricately involved as major risk factors in the pathogenesis of oral cancer (<xref rid="B5" ref-type="bibr">Chamoli et&#x000a0;al., 2021</xref>; <xref rid="B29" ref-type="bibr">Tan et&#x000a0;al., 2023</xref>). The mechanisms of pathogenesis also vary, and unidentified risk factors may exist. Cancer is a multifactorial disease caused by various genetic abnormalities (<xref rid="B12" ref-type="bibr">Hanahan and Weinberg, 2011</xref>), and its pathogenesis can involve the induction of an oncogenic inflammatory environment, DNA damage, and the production of molecules involved in tumorigenic signaling by the surrounding bacterial flora (<xref rid="B23" ref-type="bibr">Plottel and Blaser, 2011</xref>; <xref rid="B6" ref-type="bibr">Cho and Blaser, 2012</xref>). <italic>Helicobacter pylori</italic> has been found to cause gastric cancer (<xref rid="B24" ref-type="bibr">Polk and Peek, 2010</xref>); since this discovery, studies have also focused on the involvement of specific microorganisms in cancer development. Examples include typhoid bacteria as a possible risk factor for gallbladder cancer (<xref rid="B10" ref-type="bibr">Espinoza et&#x000a0;al., 2016</xref>) and human papillomavirus (HPV) being associated with cancers at various sites, including the cervix and mid-pharynx (<xref rid="B9" ref-type="bibr">Egawa, 2023</xref>). Furthermore, recent studies have demonstrated that oral microbiota are involved in tumor development and progression (<xref rid="B27" ref-type="bibr">Sun et&#x000a0;al., 2020</xref>). In addition to the involvement of HPV (<xref rid="B27" ref-type="bibr">Sun et&#x000a0;al., 2020</xref>) and <italic>Candida albicans</italic> (<xref rid="B32" ref-type="bibr">Wang et&#x000a0;al., 2023</xref>), the major periodontopathogenic bacteria <italic>Fusobacterium nucleatum</italic> and <italic>Porphyromonas gingivalis</italic> are particularly relevant. These bacteria trigger excessive inflammatory responses, evade the immune system, have anti-apoptotic activity, cause cellular transformation, and promote cancer (<xref rid="B14" ref-type="bibr">Karpi&#x00144;ski, 2019</xref>; <xref rid="B17" ref-type="bibr">Li et&#x000a0;al., 2023</xref>).</p><p>More than 700 species of bacteria are present in the oral cavity and play an important role in maintaining a healthy oral environment by forming complex commensal flora; however, some bacteria are pathogenic and can cause oral diseases. Among the commensal bacteria inhabiting the oral cavity, <italic>Streptococcus</italic> is the most abundant at the genus level (<xref rid="B7" ref-type="bibr">Costalonga and Herzberg, 2014</xref>). Bacteria of the genus <italic>Streptococcus</italic> can exhibit both beneficial effects and pathogenicity in the oral cavity. While <italic>Streptococcus salivarius</italic> and <italic>Streptococcus mitis</italic> inhibit the growth of pathogenic bacteria, <italic>Streptococcus sanguinis</italic> and <italic>S. mitis</italic> are known to cause infective endocarditis (<xref rid="B22" ref-type="bibr">Okahashi et&#x000a0;al., 2022</xref>; <xref rid="B13" ref-type="bibr">Jenkinson, 2011</xref>). <italic>Streptococcus anginosus</italic> is a causative agent of odontogenic infections (<xref rid="B2" ref-type="bibr">Asam and Spellerberg, 2014</xref>), whereas <italic>Streptococcus mutans</italic> and <italic>Streptococcus sobrinus</italic> metabolize sugars to produce acid, contributing to dental caries (<xref rid="B13" ref-type="bibr">Jenkinson, 2011</xref>). Thus, <italic>Streptococcus</italic> species are closely associated with other microorganisms and various diseases; however, their relationship with oral cancer remains largely unknown. In a previous study, saliva from patients with OSCC lesions contained more <italic>Capnocytophaga gingivalis</italic>, <italic>Prevotella melaninogenica</italic>, and <italic>S. mitis</italic> than saliva from cancer-free individuals, although the reasons for this difference are unclear. As mentioned above, the interaction of <italic>F. nucleatum</italic> and <italic>P. gingivalis</italic> with oral cancer has been demonstrated. However, the influence of <italic>Streptococcus</italic> spp., the most abundant genus in the oral cavity, on OSCC remains unclear, and its exact role in the pathogenesis of cancer remains unknown, although the association of the latter with <italic>S. anginosus</italic> has been pointed out (<xref rid="B26" ref-type="bibr">Sasaki et&#x000a0;al., 2005</xref>). Reports on other <italic>Streptococcus</italic> species are also limited. Considering that the effects of the main components of oral flora on oral cancer should be taken into account, the present study aimed to elucidate the effects of <italic>Streptococcus</italic> spp. on oral cancer cells <italic>in vitro.</italic>
</p></sec><sec sec-type="materials|methods" id="s2"><label>2</label><title>Materials and methods</title><sec id="s2_1"><label>2.1</label><title>Cell and bacterial culture</title><p>The OSCC strains HSC-3 (from human tongue carcinoma) and Ca9-22 (from human gingival carcinoma) were obtained from the Japanese Collection of Research Bioresources (JCRB; Osaka, Japan). HSC-3 cells were cultured in Eagle&#x02019;s Minimum Essential Medium (E-MEM; FUJIFILM Wako Pure Chemical Co., Osaka, Japan) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (SMPC). Ca9-22 cells were cultured in Minimum Essential Medium &#x003b1; (MEM&#x003b1;; FUJIFILM Wako Pure Chemical Co.) with 10% FBS and 1% SMPC. Both strains were incubated at 37&#x000b0;C in a 5% CO<sub>2</sub> environment.</p><p>The model bacterial strains used were <italic>S. mitis</italic> ATCC 49456, <italic>S. sanguinis</italic> ATCC 10556, <italic>S. anginosus</italic> ATCC 33379, <italic>S. salivarius</italic> ATCC BAA- 1024, and <italic>S. mutans</italic> UA 159. Brain Heart Infusion (BHI; BD, Franklin Lakes, NJ) agar medium containing 1% yeast extract (BD) was used for all bacterial cultures, and the bacteria were incubated for 1 to 2 days at 37&#x000b0;C in a 5% CO<sub>2</sub> environment. Single colonies were seeded on BHI liquid medium and incubated for 12 h at 37&#x000b0;C, 5% CO<sub>2</sub>. The culture medium (5 mL) was prepared to achieve a turbidity of 0.4 at 600 nm, and all precipitates were resuspended in an equal volume of E-MEM or MEM&#x003b1; with FBS and 1% SMPC after centrifugation at 3500 &#x000d7; <italic>g</italic> for 10 min. The centrifugation and resuspension processes were repeated twice to wash the pellets. After washing, the colony-forming units (CFUs) were counted by plating the culture onto BHI agar.</p></sec><sec id="s2_2"><label>2.2</label><title>Cell viability assay</title><p>Cell viability was assessed using a Cell Counting Kit-8 with WST-8 (CCK-8; Dojin Chemical Laboratory, Kumamoto, Japan). Briefly, HSC-3 and Ca9-22 cells were cultured and adhered in 96-well plates at 2000 cells/well for 6 h. Each bacterial solution, resuspended in cell culture medium, was prepared 100&#x02013;0.1 v/v% by 2-fold serial dilution in a separate 96-well plate. Then 50 &#x003bc;L of each bacterial solution was added to 50 &#x003bc;L of cancer cells (100 &#x003bc;L total). After 48 h of incubation, 10 &#x000b5;L of CCK-8 was added and incubated at 37&#x000b0;C for 2 h. The absorbance of each well at 450 nm was measured using a microplate reader (Multiskan FD, Thermo Fisher Scientific, Waltham, MA). All experiments were conducted with at least three biological replicates.</p></sec><sec id="s2_3"><label>2.3</label><title>Changes in gene expression</title><p>Total RNA was extracted from each sample using the Cica Geneus RNA Prep Kit (for tissue) (Kanto Chemical, Tokyo, Japan). After culturing the cells for 48 h in the presence of bacterial solution, RNA was extracted. The quality and quantity (concentration &#x02265; 40 ng/&#x003bc;L, A260/A230 &#x02265; 2.0, and A260/A280 = 1.8&#x02013;2.2) were evaluated using a Nanodrop (Thermo Fisher Scientific). Total RNA was provided to Novogene (China) for RNA sequencing using Nova Seq 6000 (Illumina Inc., San Diego, CA, USA). The raw data in FASTQ format were processed using Novogene&#x02019;s Perl script and cleaned by removing adapter-containing reads, poly-N-containing reads, and low-quality reads. The reference genome index was constructed using Hisat2 v2.0.5, and paired-end clean 1 read were aligned to the reference genome using Hisat2 v2.0.5. Gene expression levels were quantified using featureCounts v1.5.0-p3. Differential expression was analyzed using the DESeq2R package (1.20.0). Genes with adjusted <italic>p</italic>-values of &#x0003c; 0.05 in DESeq2 were considered differentially expressed genes. Gene Ontology (GO) functional analysis was performed using the clusterProfiler R package with gene length bias correction. GO terms with adjusted <italic>p</italic>-values of &#x0003c; 0.05 were considered to have significantly changed functions due to differentially expressed genes. For real-time RT-qPCR, RNA was reverse-transcribed and amplified according to previously described methods (<xref rid="B1" ref-type="bibr">Ariyoshi et&#x000a0;al., 2017</xref>). RNA expression was analyzed by real-time RT-qPCR using the AriaMx Real-Time PCR system (Agilent Technologies, Santa Clara, CA). The primer sequences used for RT-qPCR are listed in <xref rid="T1" ref-type="table">
<bold>Table&#x000a0;1</bold>
</xref>.</p><table-wrap position="float" id="T1"><label>Table&#x000a0;1</label><caption><p>The primer sequences used for RT-qPCR.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="center" rowspan="1" colspan="1">Gene name</th><th valign="middle" align="center" rowspan="1" colspan="1"/><th valign="middle" align="center" rowspan="1" colspan="1">Primer sequence (5&#x02032;-3&#x02032;)</th></tr></thead><tbody><tr><td valign="middle" rowspan="2" align="center" colspan="1">
<italic>GAPDH</italic>
</td><td valign="middle" align="left" rowspan="1" colspan="1">Forward</td><td valign="middle" align="left" rowspan="1" colspan="1">GAC GGC CGC ATC TTC TTG T</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Reverse</td><td valign="middle" align="left" rowspan="1" colspan="1">CAC ACC GAC CTT CAC CAT TTT</td></tr><tr><td valign="middle" rowspan="2" align="center" colspan="1">
<italic>DUSP1</italic>
</td><td valign="middle" align="left" rowspan="1" colspan="1">Forward</td><td valign="middle" align="left" rowspan="1" colspan="1">CCA TCT GCC TTG CTT ACC TTA T</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Reverse</td><td valign="middle" align="left" rowspan="1" colspan="1">GCT GAA GTT GGG AGA GAT GAT G</td></tr></tbody></table></table-wrap></sec><sec id="s2_4"><label>2.4</label><title>Flow cytometry analysis of bacterial effects on the cell cycle</title><p>After a 6 h pre-culture, 7 &#x000d7; 10<sup>5</sup> HSC-3 cells were seeded per Petri dish (10 cm in diameter) for 24 h. Then, the <italic>S. mitis</italic> bacterial solution was added, and the cells were fixed in 70% ethanol for 2 h. The fixed cells were treated with PI/RNase solution (IMMUNOSTEP, Salamanca, Spain). The fluorescence intensity of the cells was observed using a flow cytometer (CytoFLEX; Beckman Coulter, Brea, CA).</p></sec><sec id="s2_5"><label>2.5</label><title>Effects of intact bacteria and bacterial components on cancer cells</title><p>Live bacteria, secretions of live bacteria, and dead bacteria (sonicated and treated with isopropanol) were used as samples. Culture supernatants were prepared to achieve an optical density of 0.4 at 600 nm of the bacterial culture medium, and the supernatant fluid after centrifugation was extracted by passing it through a 0.2 &#x000b5;m filter. Samples of dead bacteria were obtained by treating live bacteria with 70% isopropanol for 1 h. The bacterial solution was sonicated using an ultrasonic homogenizer (SFX150, Branson Ultrasonics, Brookfield, CT) at 15-second intervals for 5 min, and the solution containing the disrupted bacterial cells was further centrifuged (3500 &#x000d7; <italic>g</italic> for 10 min) to separate the internal components of the bacteria (supernatant) from other bacterial structures (precipitate). The sonicated bacteria were treated with Proteinase K at 65&#x000b0;C for 2 h, then the protease was inactivated at 98&#x000b0;C for 10 min to prepare samples of the bacterial components excluding proteins. Each bacterial solution was added to HSC-3 cells for the cell viability assay. The LIVE/DEAD Viability/Cytotoxicity Kit (Thermo Fisher Scientific) was used to stain live and dead bacteria (sonicated and treated with isopropanol) to observe them under a fluorescence microscope.</p></sec><sec id="s2_6"><label>2.6</label><title>Statistical analysis</title><p>All data were expressed as mean &#x000b1; standard deviation (SD). Student&#x02019;s t-test was used for comparisons between two groups using Microsoft Excel. For comparisons between three or more groups, the statistical analysis software EZR was used to perform one-way analysis of variance (ANOVA) with Tukey&#x02019;s <italic>post hoc</italic> test.</p></sec></sec><sec sec-type="results" id="s3"><label>3</label><title>Results</title><sec id="s3_1"><label>3.1</label><title>
<italic>Streptococcus mitis</italic> most effectively inhibits cancer cell growth</title><p>To compare the effects of different bacterial species, bacterial solutions of <italic>S. mitis</italic>, <italic>S. mutans</italic>, <italic>S. sanguinis</italic>, <italic>S. anginosus</italic>, and <italic>S. salivarius</italic> were added for 48 h to HSC-3 cells pre-cultured two-dimensionally in 96-well plates. The number of viable cells was evaluated using the CCK-8 assay. The results are shown in <xref rid="f1" ref-type="fig">
<bold>Figures&#x000a0;1A&#x02013;E</bold>
</xref>.</p><fig position="float" id="f1"><label>Figure&#x000a0;1</label><caption><p>Proliferation of HSC-3 cells, as assessed using the CCK-8 assay, when <bold>(A)</bold>
<italic>S. mitis</italic>, <bold>(B)</bold>
<italic>S. mutans</italic>, <bold>(C)</bold>
<italic>S. sanguinis</italic>, <bold>(D)</bold>
<italic>S. anginosus</italic>, and <bold>(E)</bold>
<italic>S. salivarius</italic> were added (n = 3). The vertical axis represents the bacterial solution concentration (v/v%), and the horizontal axis shows the fold change. *<italic>p</italic> &#x0003c; 0.05, **<italic>p</italic> &#x0003c; 0.01 (Tukey&#x02019;s test after one-way analysis of variance).</p></caption><graphic xlink:href="fcimb-15-1524820-g001" position="float"/></fig><p>Most bacteria inhibited HSC-3 growth in a dose-dependent manner. <italic>S. mitis</italic> significantly inhibited growth at concentrations above 0.78% (<xref rid="f1" ref-type="fig">
<bold>Figure&#x000a0;1A</bold>
</xref>); <italic>S. mutans and S. salivarius</italic> significantly inhibited only at the highest concentration of 50% (<xref rid="f1" ref-type="fig">
<bold>Figures&#x000a0;1B, E</bold>
</xref>); <italic>S. sanguinis</italic> significantly inhibited at concentrations of &#x0003e; 25% (<xref rid="f1" ref-type="fig">
<bold>Figure&#x000a0;1C</bold>
</xref>); and <italic>S. anginosus</italic> significantly inhibited cell growth at concentrations of &#x0003e; 6.25% (<xref rid="f1" ref-type="fig">
<bold>Figure&#x000a0;1D</bold>
</xref>). The concentrations at which cancer cells were inhibited by 80% (IC80) compared to the control group (0%) are shown in <xref rid="T2" ref-type="table">
<bold>Table&#x000a0;2</bold>
</xref>. Among these, <italic>S. mitis</italic> showed the highest inhibition of cancer cell growth. The results of the WST-8 assay when <italic>S. mitis</italic> was added to Ca9-22 cells are shown in <xref rid="f2" ref-type="fig">
<bold>Figure&#x000a0;2</bold>
</xref>. Although the sensitivity of Ca9-22 cells was inferior to that of HSC-3 cells, significant inhibition of cell proliferation was observed with bacterial concentrations above 3.13%.</p><table-wrap position="float" id="T2"><label>Table&#x000a0;2</label><caption><p>IC80 of HSC-3 cells following the addition of <italic>S. mitis</italic>, <italic>S. mutans</italic>, <italic>S. sanguinis</italic>, <italic>S. anginosus</italic>, and <italic>S. salivarius</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="center" rowspan="1" colspan="1">Bacteria</th><th valign="middle" align="center" rowspan="1" colspan="1">IC80 (v/v%)</th></tr></thead><tbody><tr><td valign="middle" align="center" rowspan="1" colspan="1">
<italic>S. mitis</italic>
</td><td valign="middle" align="center" rowspan="1" colspan="1">0.78</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">
<italic>S. mutans</italic>
</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">
<italic>S. sanguinis</italic>
</td><td valign="middle" align="center" rowspan="1" colspan="1">25</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">
<italic>S. anginosus</italic>
</td><td valign="middle" align="center" rowspan="1" colspan="1">12.5</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">
<italic>S. salivarius</italic>
</td><td valign="middle" align="center" rowspan="1" colspan="1">50</td></tr></tbody></table></table-wrap><fig position="float" id="f2"><label>Figure&#x000a0;2</label><caption><p>Cell proliferation when <italic>S. mitis</italic> bacteria were added to Ca9-22 cells, as assessed using the CCK-8 assay (n = 3). The vertical axis represents the concentration of bacterial solution (v/v%), and the horizontal axis shows the fold change. *<italic>p</italic> &#x0003c; 0.05, **<italic>p</italic> &#x0003c; 0.01 (Tukey&#x02019;s test after one-way analysis of variance).</p></caption><graphic xlink:href="fcimb-15-1524820-g002" position="float"/></fig></sec><sec id="s3_2"><label>3.2</label><title>A group of genes involved in mitosis and nuclear division</title><p>
<italic>S. mitis</italic> was added to HSC-3 cells at 1.56%, a concentration that significantly inhibited HSC-3 cell growth (see section 3.1), and RNA was extracted from these cells. The CFU of <italic>S. mitis</italic> at 1.56% was 3.8 &#x000d7; 10<sup>6</sup> CFU/mL. The multiplicity of infection (MOI) was calculated to be 190. The effects of the bacterial species on gene expression were verified via RNA sequencing. The results of the GO enrichment analysis are shown in <xref rid="f3" ref-type="fig">
<bold>Figure&#x000a0;3A</bold>
</xref> where the 30 most important GO terms are displayed. The color represents the level of significance, and the dot size represents the number of genes. The number of genes involved in mitosis and nuclear division was significantly increased in the group incubated with <italic>S. mitis</italic> (<xref rid="f3" ref-type="fig">
<bold>Figure&#x000a0;3A</bold>
</xref>). The specific genes included in this gene group are shown in <xref rid="SM1" ref-type="supplementary-material">
<bold>Supplementary Figure&#x000a0;1</bold>
</xref>. DUSP1 expression, which satisfied the conditions |log2(Fold Change) | &#x02265; 1 and adjusted p &#x02264; 0.05, was validated by RT-qPCR (<xref rid="f3" ref-type="fig">
<bold>Figure&#x000a0;3B</bold>
</xref>).</p><fig position="float" id="f3"><label>Figure&#x000a0;3</label><caption><p>
<bold>(A)</bold> Gene expression in HSC-3 cells treated with <italic>S. mitis.</italic> The vertical axis shows the most significant GO term from the bottom up. The horizontal axis shows the ratio of the number of differentially expressed genes linked to the GO term to the total number of differentially expressed genes. The size of the points indicates the number of genes annotated to a specific GO term, and the color indicates the significant level of enrichment. <bold>(B)</bold>
<italic>DUSP1</italic> mRNA levels in HSC-3 cells treated with <italic>S. mitis</italic> (n = 3). *<italic>p</italic> &#x0003c; 0.05, **<italic>p</italic> &#x0003c; 0.01 (Student&#x02019;s t-test).</p></caption><graphic xlink:href="fcimb-15-1524820-g003" position="float"/></fig><p>The results showed a significant increase in <italic>DUSP1</italic> gene expression in the <italic>S. mitis-added</italic> group, which was consistent with the RNA sequencing results. In addition, the directed acyclic graph of biological processes allowed us to visualize the enriched GO terms of differentially expressed genes and their hierarchy (<xref rid="SM1" ref-type="supplementary-material">
<bold>Supplementary Figure&#x000a0;2</bold>
</xref>). The functional range in this figure becomes more specific from top to bottom. Given the presence of cell cycle genes high up in this hierarchy, we next investigated the cell cycle of stimulated cancer cells.</p></sec><sec id="s3_3"><label>3.3</label><title>
<italic>S. mitis</italic> treatment decreases the percentage of HSC-3 cells in the G0/G1 phase and increases that in the G2/M phase</title><p>In flow cytometry experiments, HSC-3 cells were incubated with a 1.56% dilution of <italic>S. mitis</italic> bacterial suspension (see section 3.2), and changes in the cell cycle were measured. <xref rid="f4" ref-type="fig">
<bold>Figure&#x000a0;4A</bold>
</xref> shows a histogram of the flow cytometry results of the cell cycle changes induced by <italic>S. mitis</italic>. The percentage of cells in the G0/G1 phase decreased and that in the G2/M phase increased in the <italic>S. mitis-treated</italic> group (<xref rid="f4" ref-type="fig">
<bold>Figure&#x000a0;4B</bold>
</xref>). As the proliferation of cancer cells was inhibited by <italic>S. mitis</italic>, these bacteria may have inhibited the proliferation of HSC-3 cells by arresting them in the G2/M phase.</p><fig position="float" id="f4"><label>Figure&#x000a0;4</label><caption><p>Cell cycle changes of HSC-3 cells treated with <italic>S. mitis</italic>. The cells were stained with propidium iodide (PI) and analyzed using a flow cytometer. <bold>(A)</bold> The DNA content and cell count of the cell population are shown. The vertical axis represents the cell count, and the horizontal axis shows the DNA fluorescence intensity. <bold>(B)</bold> Comparison of the percentage of cells in each region analyzed by flow cytometry. *<italic>p</italic> &#x0003c; 0.05, **<italic>p</italic> &#x0003c; 0.01 (Student&#x02019;s t-test).</p></caption><graphic xlink:href="fcimb-15-1524820-g004" position="float"/></fig></sec><sec id="s3_4"><label>3.4</label><title>Live and dead <italic>S. mitis</italic>, but not secretions of <italic>S. mitis</italic>, inhibit the growth of cancer cells</title><p>To identify the mechanism by which <italic>S. mitis</italic> inhibits the growth of HSC-3 cells, samples with various concentrations of live and dead <italic>S. mitis</italic> were added to HSC-3 cells. The supernatant of centrifuged culture media comprised BHI medium and bacterial secretions. The supernatants containing bacterial secretions at concentrations of 12.5% and 25% showed a significant decrease in growth inhibition compared to supernatants containing only BHI. These results suggest that most of the growth-inhibitory effect of the culture supernatant was due to BHI, whereas bacterial secretions had only a minor contribution (<xref rid="f5" ref-type="fig">
<bold>Figure&#x000a0;5A</bold>
</xref>). The WST-8 results (<xref rid="f5" ref-type="fig">
<bold>Figure&#x000a0;5B</bold>
</xref>) are similar to those for viable <italic>S. mitis</italic> (section 3.1). Ultrasonically disrupted <italic>S. mitis</italic> samples inhibited cell growth at concentrations of &#x0003e; 0.78%, similar to live <italic>S. mitis</italic> samples (<xref rid="f5" ref-type="fig">
<bold>Figure&#x000a0;5C</bold>
</xref>). However, chemical disruption of bacteria by isopropanol treatment did not inhibit HSC-3 growth at any concentration (<xref rid="f5" ref-type="fig">
<bold>Figure&#x000a0;5D</bold>
</xref>).</p><fig position="float" id="f5"><label>Figure&#x000a0;5</label><caption><p>Cell proliferation when processed <italic>S. mitis</italic> (<bold>(A)</bold> secretion, <bold>(B)</bold> intact <italic>S. mitis</italic>, <bold>(C)</bold> sonication (whole sample), <bold>(D)</bold> isopropanol, <bold>(E)</bold> sonication-precipitate, <bold>(F)</bold> sonication-supernatant, and <bold>(G)</bold> sonication-Proteinase K) was added to HSC-3. Cell proliferation was evaluated using the CCK-8 assay (n = 3). The vertical axis shows the concentration of the bacterial solution (v/v%), and the horizontal axis represents the fold change. *<italic>p</italic> &#x0003c; 0.05, **<italic>p</italic> &#x0003c; 0.01 (Tukey&#x02019;s test after one-way analysis of variance).</p></caption><graphic xlink:href="fcimb-15-1524820-g005" position="float"/></fig><p>The ultrasonicated material was separated by centrifugation into cell wall components (precipitate) and bacterial contents (supernatant) to examine their separate effects. After sonication and centrifugation, the precipitate inhibited growth at &#x02265; 0.78%, as did the viable and sonicated samples (<xref rid="f5" ref-type="fig">
<bold>Figure&#x000a0;5E</bold>
</xref>). Similarly, the supernatant inhibited cell growth at concentrations of &#x0003e; 12.5%, indicating that supernatants were less effective than the precipitate (<xref rid="f5" ref-type="fig">
<bold>Figure&#x000a0;5F</bold>
</xref>). This suggests that the cell wall components of <italic>S. mitis</italic> are important for inhibiting cell growth. Cell wall components include lipid bilayers and membrane proteins. To determine which components are particularly important, the proteins were inactivated. Ultrasonically crushed bacteria treated with Proteinase K to degrade proteins achieved cell growth inhibition at concentrations of &#x0003e; 25% (<xref rid="f5" ref-type="fig">
<bold>Figure&#x000a0;5G</bold>
</xref>). Protein degradation resulted in a decreased growth inhibition, indicating that protein components of the bacterial cell wall affect the growth inhibition of cancer cells. The viability of bacteria after isopropanol treatment and sonication was confirmed using LIVE/DEAD staining (<xref rid="SM1" ref-type="supplementary-material">
<bold>Supplementary Figure&#x000a0;3</bold>
</xref>). Based on the above results of the WST-8 assay, the IC80 concentrations for cancer cell inhibition compared to control conditions are summarized in <xref rid="T3" ref-type="table">
<bold>Table&#x000a0;3</bold>
</xref>.</p><table-wrap position="float" id="T3"><label>Table&#x000a0;3</label><caption><p>IC80 of HSC-3 cells following the addition of intact <italic>S. mitis</italic> or its components.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="center" rowspan="1" colspan="1">Bacterial component</th><th valign="middle" align="center" rowspan="1" colspan="1">IC80 (v/v%)</th></tr></thead><tbody><tr><td valign="middle" align="center" rowspan="1" colspan="1">Secretion</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">
<italic>S. mitis</italic>
</td><td valign="middle" align="center" rowspan="1" colspan="1">0.78</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Isopropanol treatment</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Sonication (whole sample)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.78</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Sonication-precipitation</td><td valign="middle" align="center" rowspan="1" colspan="1">0.78</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Sonication-supernatant</td><td valign="middle" align="center" rowspan="1" colspan="1">25</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Sonication-Proteinase K</td><td valign="middle" align="center" rowspan="1" colspan="1">25</td></tr></tbody></table></table-wrap></sec></sec><sec sec-type="discussion" id="s4"><label>4</label><title>Discussion</title><p>In the present study, we investigated the effects of major strains of the genus <italic>Streptococcus</italic> on oral cancer cells <italic>in vitro</italic>. We found that <italic>S. mitis</italic> inhibited the growth of oral cancer cells <italic>in vitro</italic>. Furthermore, we observed that <italic>S. mitis</italic> increased the expression of mitosis-related genes in HSC-3 cells and caused cell cycle arrest in the G2/M phase. This activity of <italic>S. mitis</italic> was related to structural bacterial proteins. By matching the absorbance of the culture medium to equalize the number of bacteria, we compared five species, <italic>S. mitis, S. salivarius, S. sanguinis, S. anginosus, and S. mutans</italic>, and found that <italic>S. mitis</italic> had the strongest inhibitory effect on the growth of HSC-3 cells (<xref rid="f1" ref-type="fig">
<bold>Figure&#x000a0;1</bold>
</xref>). Previous studies have shown that <italic>S. anginosus</italic> inhibits the proliferation of the OSCC cells SCC15 after 16 h of stimulation (<xref rid="B33" ref-type="bibr">Xu et&#x000a0;al., 2021</xref>) and <italic>S. mitis</italic> reduces the proliferation of OSCC CAL27 cells to less than 50%; <italic>S. sanguinis</italic> inhibits cell proliferation to the same extent as <italic>S. mitis</italic>; and <italic>S. mutans</italic> does not inhibit cell proliferation within 24&#x02013;72 h stimulation (<xref rid="B4" ref-type="bibr">Baraniya et&#x000a0;al., 2020</xref>). These results are consistent with many of our findings; however, the lack of similar effects of <italic>S. mitis and S. sanguinis</italic> treatments may be partly due to differences in susceptibility between the two cell lines used in both studies.</p><p>Although <italic>S. mitis</italic> can cause bloodstream infections in immunocompromised patients, it is a relatively harmless oral <italic>Streptococcus</italic> (<xref rid="B21" ref-type="bibr">Mitchell, 2011</xref>) and a health-related commensal organism. <italic>S. mitis</italic> is most common in the oral cavity of healthy adults with periodontal pockets less than 4 mm deep, and its percentage decreases in patients with periodontitis and periodontal pockets greater than 4 mm (<xref rid="B7" ref-type="bibr">Costalonga and Herzberg, 2014</xref>). In relation to oral cancer, <italic>S. mitis</italic> was significantly more frequently detected in the saliva of patients with OSCC (<xref rid="B20" ref-type="bibr">Mager et&#x000a0;al., 2005</xref>), while a significant decrease in <italic>S. mitis</italic> abundance has been observed as the cancer progresses (<xref rid="B34" ref-type="bibr">Yang et&#x000a0;al., 2018</xref>). Predictors of these causes include the species specificity of oral colonization by <italic>Streptococcus</italic> (<xref rid="B20" ref-type="bibr">Mager et&#x000a0;al., 2005</xref>) and changes in the oral microenvironment of patients with advanced tumors (<xref rid="B34" ref-type="bibr">Yang et&#x000a0;al., 2018</xref>). Our results suggest that <italic>S. mitis</italic> may play a protective role in patients with oral cancer by increasing the frequency of these bacteria in the oral cavity.</p><p>To confirm whether <italic>S. mitis</italic> effectively prevents the proliferation of oral cancer cells, we examined HSC-3 and Ca9-22 cells and found that the growth of both cell lines was suppressed by <italic>S. mitis</italic> (<xref rid="f2" ref-type="fig">
<bold>Figure&#x000a0;2</bold>
</xref>). In a previous study, <italic>S. mitis</italic> was co-cultured with the OSCC cell lines CAL27, SCC25, and SCC4, and growth suppression was confirmed in all cases. Therefore, we can assume that <italic>S. mitis</italic> suppresses the growth of various oral cancer cells (<xref rid="B4" ref-type="bibr">Baraniya et&#x000a0;al., 2020</xref>). In all experiments in this study, antibiotics were added to the culture medium used for cancer cells; therefore, we believe that abnormal bacterial growth did not occur.</p><p>A comprehensive survey of gene expression showed that the number of genes involved in mitotic nuclear division was significantly increased in HSC-3 cells treated with <italic>S. mitis</italic> (<xref rid="f3" ref-type="fig">
<bold>Figure&#x000a0;3A</bold>
</xref>). In this study, we focused on <italic>DUSP1</italic>, which showed the most significant changes among the specific genes included in the analyzed GO terms. DUSP1 is a dual-specificity phosphatase that regulates mitogen-activated protein kinase (MAPK) activity (<xref rid="B15" ref-type="bibr">Lawan et&#x000a0;al., 2013</xref>). DUSP1 expression is decreased in OSCC (<xref rid="B30" ref-type="bibr">Tomioka et&#x000a0;al., 2006</xref>), and DUSP1 downregulation promotes the progression of head and neck squamous cell carcinoma (<xref rid="B35" ref-type="bibr">Zhang et&#x000a0;al., 2014</xref>). In the present study, <italic>DUSP1</italic> expression was increased in HSC-3 cells whose growth was suppressed by <italic>S. mitis</italic> (<xref rid="f3" ref-type="fig">
<bold>Figure&#x000a0;3B</bold>
</xref>), suggesting that changes in MAPK signaling by DUSP1 are an important mechanism for growth suppression. According to reports on cell cycle regulation, an increase in DUSP1 expression in gastric cancer leads to a cell cycle arrest in the G1 phase (<xref rid="B18" ref-type="bibr">Li et&#x000a0;al., 2003</xref>), and it has been reported that DUSP1 expression in cumulus cells is reduced in the G0/G1 phase and increased in the S phase (<xref rid="B11" ref-type="bibr">Fu et&#x000a0;al., 2019</xref>). However, specific reports regarding the involvement of DUSP1 in the cell cycle of oral cancer cells have not been published. In the future, the effects of increased DUSP1 expression on the growth of oral cancer cells should be investigated.</p><p>According to the results of the cell cycle assay (<xref rid="f4" ref-type="fig">
<bold>Figure&#x000a0;4</bold>
</xref>), the number of HSC-3 cells stimulated with <italic>S. mitis</italic> in the G0/G1 phase decreased, whereas the number of cells in the G2/M phase increased; the proportion of cells in the S phase did not change significantly. This suggests that <italic>S. mitis</italic> induces G2/M phase arrest during the cell cycle progression of HSC-3 cells, thereby inhibiting proliferation. To the best of our knowledge, this is the first report on changes in the cell cycle following <italic>S. mitis</italic> infection of oral cancer cells. Previously, it has been reported that CAL27 cells treated with <italic>F. nucleatum</italic> showed increased proliferation and an increased G2/M phase ratio. Furthermore, when the phosphorylation inhibitor genistein was added, neither the proliferation rate nor the proportion of cells in the G2/M phase increased; however, the detailed mechanism of action is unclear (<xref rid="B16" ref-type="bibr">Li et&#x000a0;al., 2024</xref>). Thus, <italic>S. mitis</italic> may affect each stage of the cell cycle, but further investigations are required.</p><p>To elucidate the mechanism of action underlying the effects of <italic>S. mitis</italic> on HSC-3 cells, we investigated the effects of intact bacteria and bacterial components of <italic>S. mitis</italic> on cancer cells. Previous studies have reported that many of the cytotoxic effects of bacteria are caused by H<sub>2</sub>O<sub>2</sub> produced by them (<xref rid="B4" ref-type="bibr">Baraniya et&#x000a0;al., 2020</xref>). Our study findings show that culture supernatants containing bacterial secretions had almost no growth-inhibiting effect (<xref rid="f5" ref-type="fig">
<bold>Figure&#x000a0;5A</bold>
</xref>). Using a hydrogen peroxide test paper, we confirmed that the hydrogen peroxide concentration in the bacterial solution after resuspending the pellets and sonication was almost the same as that in E-MEM, the culture medium for cancer cells (<xref rid="SM1" ref-type="supplementary-material">
<bold>Supplementary Figure&#x000a0;4</bold>
</xref>). The growth-inhibiting effect did not differ when alive <italic>S. mitis</italic> was added, after it had been killed by ultrasound treatment, or when the bacterial cytoplasm content was extracted by centrifugation. Proteinase K degradation of proteins (<xref rid="B8" ref-type="bibr">Ebeling et&#x000a0;al., 1974</xref>) reduced this inhibitory effect of <italic>S. mitis</italic>, albeit not completely. These findings strongly indicate that structural proteins within <italic>S. mitis</italic> contribute significantly to its anti-proliferative effects on cancer cells. Isopropanol (70%) is used as a disinfectant and is effective against Gram-positive bacteria. Protein denaturation is believed to occur in bacteria treated with isopropanol (<xref rid="B25" ref-type="bibr">Rutala and Weber, 2019</xref>). The differences in the effects of protein degradation by Proteinase K and that by isopropanol may provide clues for elucidating the structure of specific types of structural proteins involved in the observed inhibitory effects of <italic>S. mitis</italic>.</p><p>Oral cleaning is important in the treatment of periodontal diseases (<xref rid="B19" ref-type="bibr">Loesche and Grossman, 2001</xref>). Without periodontal disease, the proportion of <italic>S. mitis</italic> is high in the oral cavity (<xref rid="B7" ref-type="bibr">Costalonga and Herzberg, 2014</xref>). Therefore, the fact that <italic>S. mitis</italic> suppresses oral cancer may support the importance of oral cleaning in patients with oral cancer. However, the possibility of unknown adverse effects of <italic>S. mitis</italic> on living organisms cannot be completely ruled out since many effects of <italic>S. mitis</italic>&#x02019; functions remain unknown. Because the inhibitory effect of <italic>S. mitis</italic> does not depend on whether the bacteria are alive or dead, it may be preferable to extract and use only the components that are important for the desired result.</p><p>This research has some limitations. First, the effects on non-cancer cells have not been investigated. It is necessary to examine whether <italic>S. mitis</italic> exerts cytotoxicity against non-cancerous cells of oral origin and to investigate the effects of <italic>S. mitis</italic> under conditions more similar to those of living organisms by using murine models of oral cancer. Second, the specific components of the bacteria that inhibit cancer cell growth have not been identified. We have shown in this study that protease treatment of the bacterial components attenuates their inhibitory effect, suggesting that structural proteins of the bacteria are important. Therefore, it would be necessary to further elucidate which proteins are important by recombining the genes involved in the expression of structural proteins of <italic>S. mitis</italic>. Third, the mechanism of action against oral cancer has not yet been fully explained. The investigation of receptors and signals on the cancer cell side and the clarification of inhibitory mechanisms may lead to the discovery of new cancer treatments.</p></sec><sec sec-type="conclusions" id="s5"><label>5</label><title>Conclusion</title><p>This study revealed that <italic>S. mitis</italic>, a <italic>Streptococcus</italic> species that is the most common oral bacterium, suppresses the growth of oral cancer cells. The mechanism by which <italic>S. mitis</italic> suppresses cancer cell growth mainly involves the growth arrest of mitotic oral cancer cells, as revealed by RNA sequencing and flow cytometry. Our findings suggest that structural proteins of <italic>S. mitis</italic> are involved in these effects. This indicates that <italic>S. mitis</italic> may carry out an important role in the prevention and treatment of oral cancer, and we assume that increasing the number of <italic>S. mitis</italic> in the oral cavity may reduce the risk of oral cancer development.</p></sec></body><back><ack><title>Acknowledgments</title><p>We would like to thank Editage (<ext-link xlink:href="http://www.editage.jp" ext-link-type="uri">www.editage.jp</ext-link>) for English language editing.</p></ack><sec sec-type="data-availability" id="s6"><title>Data availability statement</title><p>The sequencing data have been deposited in the DDBJ Sequence Read Archive under the accession number DRR665257-DRR665262.</p></sec><sec sec-type="ethics-statement" id="s7"><title>Ethics statement</title><p>Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used. Ethical approval was not required for the studies on animals in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.</p></sec><sec sec-type="author-contributions" id="s8"><title>Author contributions</title><p>II: Writing &#x02013; original draft, Formal Analysis, Investigation, Methodology, Validation. SM: Formal Analysis, Investigation, Methodology, Writing &#x02013; review &#x00026; editing. FH: Funding acquisition, Writing &#x02013; review &#x00026; editing. YY: Writing &#x02013; review &#x00026; editing. OT: Conceptualization, Writing &#x02013; review &#x00026; editing. MS: Supervision, Writing &#x02013; review &#x00026; editing. MH: Project administration, Writing &#x02013; review &#x00026; editing. WA: Conceptualization, Project administration, Supervision, Writing &#x02013; review &#x00026; editing. RY: Conceptualization, Data curation, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Validation, Writing &#x02013; review &#x00026; editing.</p></sec><sec sec-type="COI-statement" id="s10"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="s11"><title>Generative AI statement</title><p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p></sec><sec sec-type="disclaimer" id="s12"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><sec sec-type="supplementary-material" id="s13"><title>Supplementary material</title><p>The Supplementary Material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2025.1524820/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fcimb.2025.1524820/full#supplementary-material</ext-link>
</p><supplementary-material id="SM1" position="float" content-type="local-data"><media xlink:href="Table1.docx"/></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ariyoshi</surname><given-names>W.</given-names></name><name><surname>Okinaga</surname><given-names>T.</given-names></name><name><surname>Chaweewannakorn</surname><given-names>W.</given-names></name><name><surname>Akifusa</surname><given-names>S.</given-names></name><name><surname>Nisihara</surname><given-names>T.</given-names></name></person-group> (<year>2017</year>). <article-title>Mechanisms involved in enhancement of matrix metalloproteinase-9 expression in macrophages by interleukin-33</article-title>. <source>J. Cell. Physiol.</source>
<volume>232</volume>, <fpage>3481</fpage>&#x02013;<lpage>3495</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1002/jcp.25809</pub-id>
<pub-id pub-id-type="pmid">28105703</pub-id>
</mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Asam</surname><given-names>D.</given-names></name><name><surname>Spellerberg</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Molecular pathogenicity of <italic>Streptococcus anginosus</italic>
</article-title>. <source>Mol. Oral. Microbiol.</source>
<volume>29</volume>, <fpage>145</fpage>&#x02013;<lpage>155</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/omi.12056</pub-id>
<pub-id pub-id-type="pmid">24848553</pub-id>
</mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bagan</surname><given-names>J.</given-names></name><name><surname>Sarrion</surname><given-names>G.</given-names></name><name><surname>Jimenez</surname><given-names>Y.</given-names></name></person-group> (<year>2010</year>). <article-title>Oral cancer: clinical features</article-title>. <source>Oral. Oncol.</source>
<volume>46</volume>, <fpage>414</fpage>&#x02013;<lpage>417</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.oraloncology.2010.03.009</pub-id>
<pub-id pub-id-type="pmid">20400366</pub-id>
</mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baraniya</surname><given-names>D.</given-names></name><name><surname>Jain</surname><given-names>V.</given-names></name><name><surname>Lucarelli</surname><given-names>R.</given-names></name><name><surname>Tam</surname><given-names>V.</given-names></name><name><surname>Vanderveer</surname><given-names>L.</given-names></name><name><surname>Puri</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>Screening of health-associated oral bacteria for anticancer properties in <italic>vitro</italic>
</article-title>. <source>Front. Cell. Infect. Microbiol.</source>
<volume>10</volume>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3389/fcimb.2020.575656</pub-id>
</mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chamoli</surname><given-names>A.</given-names></name><name><surname>Gosavi</surname><given-names>A. S.</given-names></name><name><surname>Shirwadkar</surname><given-names>U. P.</given-names></name><name><surname>Wangdale</surname><given-names>K. V.</given-names></name><name><surname>Behera</surname><given-names>S. K.</given-names></name><name><surname>Kurrey</surname><given-names>N. K.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics</article-title>. <source>Oral. Oncol.</source>
<volume>121</volume>, <elocation-id>105451</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.oraloncology.2021.105451</pub-id>
<pub-id pub-id-type="pmid">34329869</pub-id>
</mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cho</surname><given-names>I.</given-names></name><name><surname>Blaser</surname><given-names>M. J.</given-names></name></person-group> (<year>2012</year>). <article-title>The human microbiome: at the interface of health and disease</article-title>. <source>Nat. Rev. Genet.</source>
<volume>13</volume>, <fpage>260</fpage>&#x02013;<lpage>270</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/nrg3182</pub-id>
<pub-id pub-id-type="pmid">22411464</pub-id>
</mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Costalonga</surname><given-names>M.</given-names></name><name><surname>Herzberg</surname><given-names>M. C.</given-names></name></person-group> (<year>2014</year>). <article-title>The oral microbiome and the immunobiology of periodontal disease and caries</article-title>. <source>Immunol. Lett.</source>
<volume>162</volume>, <fpage>22</fpage>&#x02013;<lpage>38</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.imlet.2014.08.017</pub-id>
<pub-id pub-id-type="pmid">25447398</pub-id>
</mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ebeling</surname><given-names>W.</given-names></name><name><surname>Hennrich</surname><given-names>N.</given-names></name><name><surname>Klockow</surname><given-names>M.</given-names></name><name><surname>Metz</surname><given-names>H.</given-names></name><name><surname>Orth</surname><given-names>H. D.</given-names></name><name><surname>Lang</surname><given-names>H.</given-names></name></person-group> (<year>1974</year>). <article-title>Proteinase K from <italic>Tritirachium album</italic> limber</article-title>. <source>Eur. J. Biochem.</source>
<volume>47</volume>, <fpage>91</fpage>&#x02013;<lpage>97</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/j.1432-1033.1974.tb03671.x</pub-id>
<pub-id pub-id-type="pmid">4373242</pub-id>
</mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Egawa</surname><given-names>N.</given-names></name></person-group> (<year>2023</year>). <article-title>Papillomaviruses and cancer: commonalities and differences in HPV carcinogenesis at different sites of the body</article-title>. <source>Int. J. Clin. Oncol.</source>
<volume>28</volume>, <fpage>956</fpage>&#x02013;<lpage>964</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s10147-023-02340-y</pub-id>
<pub-id pub-id-type="pmid">37199886</pub-id>
</mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Espinoza</surname><given-names>J. A.</given-names></name><name><surname>Bizama</surname><given-names>C.</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>P.</given-names></name><name><surname>Ferreccio</surname><given-names>C.</given-names></name><name><surname>Javle</surname><given-names>M.</given-names></name><name><surname>Miquel</surname><given-names>J. F.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>The inflammatory inception of gallbladder cancer</article-title>. <source>Biochim. Biophys. Acta</source>
<volume>1865</volume>, <fpage>245</fpage>&#x02013;<lpage>254</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.bbcan.2016.03.004</pub-id>
<pub-id pub-id-type="pmid">26980625</pub-id>
</mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fu</surname><given-names>X. H.</given-names></name><name><surname>Chen</surname><given-names>C. Z.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Han</surname><given-names>D. X.</given-names></name><name><surname>Wang</surname><given-names>Y. J.</given-names></name><name><surname>Yuan</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Dual-specificity phosphatase 1 regulates cell cycle progression and apoptosis in cumulus cells by affecting mitochondrial function, oxidative stress, and autophagy</article-title>. <source>Am. J. Physiol. Cell Physiol.</source>
<volume>317</volume>, <fpage>C1183</fpage>&#x02013;<lpage>C1193</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1152/ajpcell.00012.2019</pub-id>
<pub-id pub-id-type="pmid">31532716</pub-id>
</mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hanahan</surname><given-names>D.</given-names></name><name><surname>Weinberg</surname><given-names>R. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Hallmarks of cancer: the next generation</article-title>. <source>Cell</source>
<volume>144</volume>, <fpage>646</fpage>&#x02013;<lpage>674</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id>
<pub-id pub-id-type="pmid">21376230</pub-id>
</mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jenkinson</surname><given-names>H. F.</given-names></name></person-group> (<year>2011</year>). <article-title>Beyond the oral microbiome</article-title>. <source>Environ. Microbiol.</source>
<volume>13</volume>, <fpage>3077</fpage>&#x02013;<lpage>3087</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/j.1462-2920.2011.02573.x</pub-id>
<pub-id pub-id-type="pmid">21906224</pub-id>
</mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karpi&#x00144;ski</surname><given-names>T. M.</given-names></name></person-group> (<year>2019</year>). <article-title>Role of oral microbiota in cancer development</article-title>. <source>Microorganisms</source>
<volume>7</volume>, <elocation-id>20</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3390/microorganisms7010020</pub-id>
<pub-id pub-id-type="pmid">30642137</pub-id>
</mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lawan</surname><given-names>A.</given-names></name><name><surname>Shi</surname><given-names>H.</given-names></name><name><surname>Gatzke</surname><given-names>F.</given-names></name><name><surname>Bennett</surname><given-names>A. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Diversity and specificity of the mitogen-activated protein kinase phosphatase-1 functions</article-title>. <source>Cell. Mol. Life Sci.</source>
<volume>70</volume>, <fpage>223</fpage>&#x02013;<lpage>237</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s00018-012-1041-2</pub-id>
<pub-id pub-id-type="pmid">22695679</pub-id>
</mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Fu</surname><given-names>R.</given-names></name><name><surname>Wen</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2024</year>). <article-title>
<italic>F. Nucleatum</italic> enhances oral squamous cell carcinoma proliferation via E-cadherin/&#x003b2;-Catenin pathway</article-title>. <source>BMC Oral. Health</source>
<volume>24</volume>, <fpage>518</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1186/s12903-024-04252-3</pub-id>
<pub-id pub-id-type="pmid">38698370</pub-id>
</mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Xiao</surname><given-names>L.</given-names></name><name><surname>Gong</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2023</year>). <article-title>Role of oral microbiome in oral oncogenesis, tumor progression, and metastasis</article-title>. <source>Mol. Oral. Microbiol.</source>
<volume>38</volume>, <fpage>9</fpage>&#x02013;<lpage>22</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/omi.12403</pub-id>
<pub-id pub-id-type="pmid">36420924</pub-id>
</mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Zhou</surname><given-names>J. Y.</given-names></name><name><surname>Ge</surname><given-names>Y.</given-names></name><name><surname>Matherly</surname><given-names>L. H.</given-names></name><name><surname>Wu</surname><given-names>G. S.</given-names></name></person-group> (<year>2003</year>). <article-title>The phosphatase MKP1 is a transcriptional target of p53 involved in cell cycle regulation</article-title>. <source>J. Biol. Chem.</source>
<volume>278</volume>, <fpage>41059</fpage>&#x02013;<lpage>41068</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1074/jbc.M307149200</pub-id>
<pub-id pub-id-type="pmid">12890671</pub-id>
</mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Loesche</surname><given-names>W. J.</given-names></name><name><surname>Grossman</surname><given-names>N. S.</given-names></name></person-group> (<year>2001</year>). <article-title>Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment</article-title>. <source>Clin. Microbiol. Rev.</source>
<volume>14</volume>, <fpage>727</fpage>&#x02013;<lpage>752</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1128/CMR.14.4.727-752.2001</pub-id>
<pub-id pub-id-type="pmid">11585783</pub-id>
</mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mager</surname><given-names>D. L.</given-names></name><name><surname>Haffajee</surname><given-names>A. D.</given-names></name><name><surname>Devlin</surname><given-names>P. M.</given-names></name><name><surname>Norris</surname><given-names>C. M.</given-names></name><name><surname>Posner</surname><given-names>M. R.</given-names></name><name><surname>Goodson</surname><given-names>J. M.</given-names></name></person-group> (<year>2005</year>). <article-title>The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects</article-title>. <source>J. Transl. Med.</source>
<volume>3</volume>, <elocation-id>27</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1186/1479-5876-3-27</pub-id>
<pub-id pub-id-type="pmid">15987522</pub-id>
</mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>
<italic>Streptococcus mitis</italic>: walking the line between commensalism and pathogenesis</article-title>. <source>Mol. Oral. Microbiol.</source>
<volume>26</volume>, <fpage>89</fpage>&#x02013;<lpage>98</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/j.2041-1014.2010.00601.x</pub-id>
<pub-id pub-id-type="pmid">21375700</pub-id>
</mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Okahashi</surname><given-names>N.</given-names></name><name><surname>Nakata</surname><given-names>M.</given-names></name><name><surname>Kuwata</surname><given-names>H.</given-names></name><name><surname>Kawabata</surname><given-names>S.</given-names></name></person-group> (<year>2022</year>). <article-title>Oral mitis group streptococci: A silent majority in our oral cavity</article-title>. <source>Microbiol. Immunol.</source>
<volume>66</volume>, <fpage>539</fpage>&#x02013;<lpage>551</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/1348-0421.13028</pub-id>
<pub-id pub-id-type="pmid">36114681</pub-id>
</mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Plottel</surname><given-names>C. S.</given-names></name><name><surname>Blaser</surname><given-names>M. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Microbiome and Malignancy</article-title>. <source>Cell Host Microbe</source>
<volume>10</volume>, <fpage>324</fpage>&#x02013;<lpage>335</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.chom.2011.10.003</pub-id>
<pub-id pub-id-type="pmid">22018233</pub-id>
</mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Polk</surname><given-names>D. B.</given-names></name><name><surname>Peek</surname><given-names>R. M.</given-names></name></person-group> (<year>2010</year>). <article-title>
<italic>Helicobacter pylori</italic>: gastric cancer and beyond</article-title>. <source>Nat. Rev. Cancer</source>
<volume>10</volume>, <fpage>403</fpage>&#x02013;<lpage>414</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/nrc2857</pub-id>
<pub-id pub-id-type="pmid">20495574</pub-id>
</mixed-citation></ref><ref id="B25"><mixed-citation publication-type="webpage">
<person-group person-group-type="author"><name><surname>Rutala</surname><given-names>W. A.</given-names></name><name><surname>Weber</surname><given-names>D. J.</given-names></name></person-group> (<year>2019</year>). <article-title>Guideline for disinfection and sterilization in healthcare facilitie</article-title>. Available online at: <uri xlink:href="https://stacks.cdc.gov/view/cdc/134910">https://stacks.cdc.gov/view/cdc/134910</uri> (Accessed October 14, 2024).</mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>M.</given-names></name><name><surname>Yamaura</surname><given-names>C.</given-names></name><name><surname>Ohara-Nemoto</surname><given-names>Y.</given-names></name><name><surname>Tajika</surname><given-names>S.</given-names></name><name><surname>Kodama</surname><given-names>Y.</given-names></name><name><surname>Ohya</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>
<italic>Streptococcus anginosus</italic> infection in oral cancer and its infection route</article-title>. <source>Oral. Dis.</source>
<volume>11</volume>, <fpage>151</fpage>&#x02013;<lpage>156</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/j.1601-0825.2005.01051.x</pub-id>
<pub-id pub-id-type="pmid">15888105</pub-id>
</mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Tang</surname><given-names>Q.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Xie</surname><given-names>M.</given-names></name><name><surname>Xie</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>Role of the oral microbiota in cancer evolution and progression</article-title>. <source>Cancer Med.</source>
<volume>9</volume>, <fpage>6306</fpage>&#x02013;<lpage>6321</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1002/cam4.3206</pub-id>
<pub-id pub-id-type="pmid">32638533</pub-id>
</mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sung</surname><given-names>H.</given-names></name><name><surname>Ferlay</surname><given-names>J.</given-names></name><name><surname>Siegel</surname><given-names>R. L.</given-names></name><name><surname>Laversanne</surname><given-names>M.</given-names></name><name><surname>Soerjomataram</surname><given-names>I.</given-names></name><name><surname>Jemal</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title>. <source>CA Cancer J. Clin.</source>
<volume>71</volume>, <fpage>209</fpage>&#x02013;<lpage>249</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3322/caac.21660</pub-id>
<pub-id pub-id-type="pmid">33538338</pub-id>
</mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tan</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Huang</surname><given-names>Z.</given-names></name><name><surname>Qin</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2023</year>). <article-title>Oral squamous cell carcinomas: state of the field and emerging directions</article-title>. <source>Int. J. Oral. Sci.</source>
<volume>15</volume>, <fpage>44</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/s41368-023-00249-w</pub-id>
<pub-id pub-id-type="pmid">37736748</pub-id>
</mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tomioka</surname><given-names>H.</given-names></name><name><surname>Morita</surname><given-names>K.</given-names></name><name><surname>Hasegawa</surname><given-names>S.</given-names></name><name><surname>Omura</surname><given-names>K.</given-names></name></person-group> (<year>2006</year>). <article-title>Gene expression analysis by cDNA microarray in oral squamous cell carcinoma</article-title>. <source>J. Oral. Pathol. Med.</source>
<volume>35</volume>, <fpage>206</fpage>&#x02013;<lpage>211</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/j.1600-0714.2006.00410.x</pub-id>
<pub-id pub-id-type="pmid">16519767</pub-id>
</mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vermaire</surname><given-names>J. A.</given-names></name><name><surname>Partoredjo</surname><given-names>A. S. K.</given-names></name><name><surname>de Groot</surname><given-names>R. J.</given-names></name><name><surname>Brand</surname><given-names>H. S.</given-names></name><name><surname>Speksnijder</surname><given-names>C. M.</given-names></name></person-group> (<year>2022</year>). <article-title>Mastication in health-related quality of life in patients treated for oral cancer: A systematic review</article-title>. <source>Eur. J. Cancer Care (Engl.)</source>
<volume>31</volume>, <fpage>e13744</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/ecc.13744</pub-id>
<pub-id pub-id-type="pmid">36239005</pub-id>
</mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><etal/></person-group>. (<year>2023</year>). <article-title>
<italic>Candida albicans</italic> promotes oral cancer via IL-17A/IL-17RA-macrophage axis</article-title>. <source>mBio</source>
<volume>14</volume>, <elocation-id>e0044723</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1128/mbio.00447-23</pub-id>
<pub-id pub-id-type="pmid">37067414</pub-id>
</mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Jia</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name></person-group> (<year>2021</year>). <article-title>Effect of <italic>Streptococcus anginosus</italic> on biological response of tongue squamous cell carcinoma cells</article-title>. <source>BMC Oral. Health</source>
<volume>21</volume>, <fpage>141</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1186/s12903-021-01505-3</pub-id>
<pub-id pub-id-type="pmid">33743656</pub-id>
</mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>C. Y.</given-names></name><name><surname>Yeh</surname><given-names>Y. M.</given-names></name><name><surname>Yu</surname><given-names>H. Y.</given-names></name><name><surname>Chin</surname><given-names>C. Y.</given-names></name><name><surname>Hsu</surname><given-names>C. W.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Oral microbiota community dynamics associated with oral squamous cell carcinoma staging</article-title>. <source>Front. Microbiol.</source>
<volume>9</volume>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3389/fmicb.2018.00862</pub-id>
</mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Hyer</surname><given-names>J. M.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>D&#x02019;Silva</surname><given-names>N. J.</given-names></name><name><surname>Kirkwood</surname><given-names>K. L.</given-names></name></person-group> (<year>2014</year>). <article-title>DUSP1 phosphatase regulates the proinflammatory milieu in head and neck squamous cell carcinoma</article-title>. <source>Cancer Res.</source>
<volume>74</volume>, <fpage>7191</fpage>&#x02013;<lpage>7197</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-14-1379</pub-id>
<pub-id pub-id-type="pmid">25312268</pub-id>
</mixed-citation></ref></ref-list></back></article>